X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

12 years of the Partnership of Prescription Assistance

By Hannah Mooney  |    April 5, 2017
Today, the Partnership for Prescription Assistance (PPA) is celebrating 12 years of helping connect patients who struggle with affordable access to the medicines they need. Because PPA serves as a...   Read More

RA medicines often demonstrate far greater benefits to patients than initially understood

By Lauren Neves  |    April 5, 2017
In the last decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients’ treatment options and significantly improved outcomes,...   Read More

NAFTA tribunal fails to rule on Canada’s patent utility doctrine

By Mark Grayson  |    April 4, 2017
While Canada may have prevailed in the recent North American Free Trade Agreement (NAFTA) tribunal case against Eli Lilly, the promise utility doctrine continues to harm their economy. And,...   Read More

ICYMI: Report highlights overall decrease in cancer death rates

By Andrew Powaleny  |    April 3, 2017
In case you missed it, cancer death rates are continuing to decrease for men, women and children in the United States thanks in part to biopharmaceutical innovation, according to the Annual Report...   Read More

Medicare Monday: A guide to MedPAC’s Part B vote this week

By Allyson Funk  |    April 3, 2017
The Medicare Payment Advisory Commission (MedPAC) is an independent congressional agency that advises Congress on issues related to the Medicare program, including payment, access to and quality...   Read More

New analysis: More than half of patients’ out-of-pocket spending for brand medicines is based on full list price

By Holly Campbell  |    March 29, 2017
More than half of commercially insured patients’ out-of-pocket spending for brand medicines is based on full list prices, according to a new analysis from Amundsen Consulting, a division of...   Read More

Resources for understanding the dangers of drug importation

By Nicole Longo  |    March 28, 2017
Recent proposals to allow drug importation from other countries are dangerous for patients and the U.S. drug supply chain. To better understand how these importation schemes could negatively...   Read More

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

By Michelle Drozd  |    March 27, 2017
In recent years we have seen remarkable scientific breakthroughs in the discovery of new therapies to treat some of the most challenging diseases faced by patients. These groundbreaking medicines...   Read More

Medicare Monday: A discussion on affordability and access to medicines

By Nicole Longo  |    March 27, 2017
In case you missed it, the American Society on Aging held its annual conference last week in Chicago, IL, where Lori Reilly, PhRMA executive vice president of policy, research & membership, spoke...   Read More

17 years (and more) of medical discoveries

By Priscilla VanderVeer  |    March 24, 2017
Someone asked me recently if donated kidneys last forever. It’s been 17 years and a few days since I received one, which has lasted 17 years longer than I thought it would. That may not be...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates